A Gartner survey of nearly 2,000 chief information officers found that 2021 will be a race to digital innovation, with organizations seeking to keep up the momentum from COVID-19 responses. The 2021 Gartner CIO Agenda survey found that the COVID-19 experience convinced many execs that remote work should continue, with just over half of… Read More »
“As working women, we have an opportunity to be an example of living with passion and priorities, of working hard, of staying committed, not necessarily to work itself but to the priorities we set around our work and our personal lives. When we work and parent simultaneously, we have a chance to teach our kids… Read More »
Essential Reads: Neurosteroids, Allopregnanolone and Vulnerability to Depression in Women Women are twice as likely as men to suffer from a depressive disorder. In addition, they are vulnerable to mood disorders associated with reproductive functioning, specifically premenstrual dysphoric disorder, perinatal depression, and perimenopausal depression. There is strong evidence to indicate that biological factors (genetic vulnerability,… Read More »
With a surprise FDA approval Friday afternoon, Kadmon Holdings is on its way to becoming a commercial drugmaker. The FDA cleared Kadmon’s Rezurock to treat chronic graft-versus-host disease, a serious complication of transplant procedures. Formerly known as belumodsil, the drug is a first-in-class ROCK2 inhibitor—and now Kadmon’s first approved drug. GVHD occurs when donor cells mount an immune response against a patient’s own tissues and organs. While doctors can… Read More »
When the COVID-19 pandemic struck, many IT leaders shadowed clinical staff to view first-hand the support those clinicians needed on the front lines. And often they learned some valuable lessons. Meanwhile, while healthcare organizations and their IT teams focused on fighting the COVID-19 crisis, hackers in the wild were not taking a break from their… Read More »